期刊文献+

SelS高表达保护人脐静脉内皮细胞免于H_2O_2诱导的细胞损伤 被引量:9

Overexpressing SelS May Protect Human Umbilical Vein Endothelial Cells From Injuring by H_2O_2
下载PDF
导出
摘要 采用以下方法探讨SelS在内皮细胞中的表达和作用:将SelS基因克隆到真核表达载体pLNCX2,RT-PCR、XhoⅠ/ClaⅠ双酶切以及DNA序列分析验证目的基因;利用脂质体转染技术将pLNCX2-SelS或pLNCX2转染至人脐静脉内皮细胞(ECV304细胞),RT-PCR检测重组基因SelS的表达;MTT方法检测转染后过氧化氢(H2O2)对内皮细胞增殖能力的影响;硫代巴比妥酸法测定暴露于H2O2中不同转染组细胞脂质过氧化产物丙二醛含量.结果表明:成功构建真核表达载体pLNCX2-SelS;转染后重组SelS mRNA表达水平是内源性水平的1.76倍;H2O2对ECV304细胞损伤后,高表达SelS组细胞活性增强、H2O2诱导产生的丙二醛减少.上述结果表明,高表达SelS可保护内皮细胞免于H2O2诱导的细胞损伤,其作用机制与抗氧化有关. In order to investigate the expression and roles of SelS in human umbilical vein endothelial cells (HUVECs, ECV304 cells), total RNAs were extracted with TRIzol from adipose tissues of human, then the 1 102 bp fragment of SelS was amplified by RT-PCR. After the expected 1 102 bp PCR fragment was purified, SelS was cloned into pMD18-T vector. Purification, RT-PCR, restriction endonuclease analysis and DNA sequencing were performed to confirm the results, pMD 18-SelS was incubated in presence of Xho Ⅰ/Cla Ⅰand then ligated into pLNCX2 vector corresponding restriction sites. RT-PCR and DNA sequencing were performed to confirm a 1 102 bp SelS gene fragment was successfully inserted into pLNCX2. The ECV304 cells were stably infected with pLNCX2-SelS or pLNCX2 alone and positive clone was obtained by G418 selection. After transient transfection, ECV304 cells expressed pLNCX2 was verified by neo' gene detection and the expression of recombinant SelS in the ECV304 cells was 1.76-fold higher than the endogenous level by RT-PCR. After the cultured ECV304 cells was treated with hydrogen peroxide (H2O2, 100, 200, 300, 400 μmol/L) for 24 h, cell viability was measured by MTT assay and the intracellular maleic dialdehyde(MDA)was detected by TBA method. The results showed that ECV304 cells were injured by H2O2, overexpressing SelS increased the cell viability apparently find inhibited the production of MDA induced by H2O2. So overexpressing SelS protects ECV304 cells from injuring by H2O2, and SelS may have the antioxidant orotection effective on endothelial cells,
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2007年第4期425-430,共6页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金资助项目(30670649)~~
关键词 内皮功能障碍 Tanis/SelS ECV304细胞 氧化应激 pLNCX2 endothelial dysfunction, Tanis/SelS, HUVECs(ECV304 cells), oxidative stress, pLNCX2
  • 相关文献

参考文献21

  • 1Dunn E J,Grant P J.Type 2 diabetes:an atherothrombotic syndrome.Curr Mol Med,2005,5 (3):323~332
  • 2Nachman R L,Jaffe E A.Endothelial cell culture:beginnings of modern vascular biology.J Clin Invest,2004,114 (8):1037~1040
  • 3Pesic S,Radenkovic M,Grbovic L.Endothelial dysfunction:mechanisms of development and therapeutic options.Med Pregl,2006,59 (7~8):335~341
  • 4Margaret A C.The potential for novel anti-inflammatory therapies for coronary artery disease.Nature Reviews Drug Discovery,2002,1 (2):122~130
  • 5Dzau V J,Braun-Dullaeus R C,Sedding D G.Vascular proliferation and atherosclerosis:New perspectives and therapeutic strategies.Nature Medicine,2002,8 (11):1249~1256
  • 6Lipinski M J,Fuster V,Fisher E A,et al.Technology insight:targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging.Nature Clinical Practice Cardiovascular Medicine,2004,1 (1):48~54
  • 7Schalkwijk C G,Stehouwer C D.Vascular complications in diabetes mellitus:the role of endothelial dysfunction.Clin Sci (Lond),2005,109 (2):143~159
  • 8Walder K,Kantham L,McMillan J S,et al.Tanis:A link between type 2 diabetes and inflammation?.Diabetes,2002,51 (6):1859~1866
  • 9Gao Y,Walder K,Sunderland T,et al.Elevation in tanis expression alters glucose metabolism and insulin sensitivity in H4IIE cells.Diabetes,2003,52 (4):929~934
  • 10Kunsch C,Medford R M.Oxidative stress as a regulator of gene expression in the vasculature.Circ Res,1999,85 (8):753~766

同被引文献75

  • 1刘洁,徐焱成.马来酸罗格列酮对大鼠Tanis mRNA表达的影响[J].医药导报,2006,25(2):114-117. 被引量:1
  • 2Luo HL,Zang W J, Lu J, et al. The protective effect of captopril on nicotine-induced endothelial dysfunction in rat. Basic Clin Pharmacol Toxicol,2006 ,99 :237-245.
  • 3Chlopicki S, Gryglewski RJ. Angiotensin converting enzyme (ACE) and hydroxy methyl glutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium. Pharmacol Rep, 2005,57:86-96.
  • 4Tesfamariam B. The effects of HMG-CoA reductase inhibitors on endothelial function. Am J Cardiovasc Drugs,2006,6 : 115-120.
  • 5Neuvonen PJ, Niemi M, Baekman JT. Drug interactions with lipidlowering drugs : mechanisms and clinical relevance. Clin Pharmacol Ther,2006,80:565-581.
  • 6Dormandy JA, Charbonnel B, Eckland D J, et al. Secondary prevention of maerovaseular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In ma- croVascular Events) : a rartdomised controlled trial. Lancet ,2005,366: 1279-1289.
  • 7Patel CB, De Lemos JA, Wyne KL, et al. Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPAR gamma agonism. Diab Vasc Dis Res,2006,3:65-71.
  • 8Tousoulis D, Boger RH, Antoniades C, et al. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective. Nat Clin Pract Cardiovasc Med,2007 ,4 :274-283.
  • 9Chen YH, Lin S J, Chen YL, et al. Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets ,2006,6:279-304.
  • 10Nan B, Lin P, Lumsden AB, et al. Effects of TNF-alpha and curcumine on the expression of thrombomodulin and endothelial protein kinase C receptor in human endothelial cells. Thromb Res,2005, 115:417-426.

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部